318 related articles for article (PubMed ID: 26304989)
1. Interaction of Macrophage Antigen 1 and CD40 Ligand Leads to IL-12 Production and Resistance in CD40-Deficient Mice Infected with Leishmania major.
Okwor I; Jia P; Uzonna JE
J Immunol; 2015 Oct; 195(7):3218-26. PubMed ID: 26304989
[TBL] [Abstract][Full Text] [Related]
2. The development of a Th1-type response and resistance to Leishmania major infection in the absence of CD40-CD40L costimulation.
Padigel UM; Perrin PJ; Farrell JP
J Immunol; 2001 Nov; 167(10):5874-9. PubMed ID: 11698463
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of CD40 Reveals an Important Role for LIGHT in Anti-Leishmania Immunity.
Okwor I; Xu G; Tang H; Liang Y; Fu YX; Uzonna JE
J Immunol; 2015 Jul; 195(1):194-202. PubMed ID: 26026056
[TBL] [Abstract][Full Text] [Related]
4. TRANCE-RANK costimulation is required for IL-12 production and the initiation of a Th1-type response to Leishmania major infection in CD40L-deficient mice.
Padigel UM; Kim N; Choi Y; Farrell JP
J Immunol; 2003 Nov; 171(10):5437-41. PubMed ID: 14607948
[TBL] [Abstract][Full Text] [Related]
5. CD40-CD40 ligand costimulation is not required for initiation and maintenance of a Th1-type response to Leishmania major infection.
Padigel UM; Farrell JP
Infect Immun; 2003 Mar; 71(3):1389-95. PubMed ID: 12595456
[TBL] [Abstract][Full Text] [Related]
6. The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb.
Ferlin WG; von der Weid T; Cottrez F; Ferrick DA; Coffman RL; Howard MC
Eur J Immunol; 1998 Feb; 28(2):525-31. PubMed ID: 9521062
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of CD40-induced N-Ras activation reduces leishmania major infection.
Chakraborty S; Srivastava A; Jha MK; Nair A; Pandey SP; Srivastava N; Kumari S; Singh S; Krishnasastry MV; Saha B
J Immunol; 2015 Apr; 194(8):3852-60. PubMed ID: 25786685
[TBL] [Abstract][Full Text] [Related]
8. Interruption of classic CD40L-CD40 signalling but not of the novel CD40L-Mac-1 interaction limits arterial neointima formation in mice.
Willecke F; Tiwari S; Rupprecht B; Wolf D; Hergeth S; Hoppe N; Dufner B; Schulte L; Anto Michel N; Bukosza N; Marchini T; Jäckel M; Stachon P; Hilgendorf I; Zeschky K; Schleicher R; Langer HF; von Zur Muhlen C; Bode C; Peter K; Zirlik A
Thromb Haemost; 2014 Aug; 112(2):379-89. PubMed ID: 24652469
[TBL] [Abstract][Full Text] [Related]
9. Underproduction of interleukin-12 in susceptible mice during progressive leishmaniasis is due to decreased CD40 activity.
Heinzel FP; Rerko RM; Hujer AM
Cell Immunol; 1998 Mar; 184(2):129-42. PubMed ID: 9630839
[TBL] [Abstract][Full Text] [Related]
10. Leishmania major: recruitment of Gr-1+ cells into draining lymph nodes during infection is important for early IL-12 and IFN gamma production.
dos Santos MS; Vaz Cardoso LP; Nascimento GR; Lino Rde S; Dorta ML; de Oliveira MA; Ribeiro-Dias F
Exp Parasitol; 2008 Jul; 119(3):403-10. PubMed ID: 18501355
[TBL] [Abstract][Full Text] [Related]
11. Vaccination against the intracellular pathogens Leishmania major and L. amazonensis by directing CD40 ligand to macrophages.
Chen G; Darrah PA; Mosser DM
Infect Immun; 2001 May; 69(5):3255-63. PubMed ID: 11292748
[TBL] [Abstract][Full Text] [Related]
12. Induction of IL-12 p40 messenger RNA expression and IL-12 production of macrophages via CD40-CD40 ligand interaction.
Kato T; Hakamada R; Yamane H; Nariuchi H
J Immunol; 1996 May; 156(10):3932-8. PubMed ID: 8621933
[TBL] [Abstract][Full Text] [Related]
13. LIGHT Is critical for IL-12 production by dendritic cells, optimal CD4+ Th1 cell response, and resistance to Leishmania major.
Xu G; Liu D; Okwor I; Wang Y; Korner H; Kung SK; Fu YX; Uzonna JE
J Immunol; 2007 Nov; 179(10):6901-9. PubMed ID: 17982081
[TBL] [Abstract][Full Text] [Related]
14. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis.
Liese J; Schleicher U; Bogdan C
Eur J Immunol; 2007 Dec; 37(12):3424-34. PubMed ID: 18034422
[TBL] [Abstract][Full Text] [Related]
15. CD40 ligand is required for protective cell-mediated immunity to Leishmania major.
Campbell KA; Ovendale PJ; Kennedy MK; Fanslow WC; Reed SG; Maliszewski CR
Immunity; 1996 Mar; 4(3):283-9. PubMed ID: 8624818
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-4-independent acceleration of cutaneous leishmaniasis in susceptible BALB/c mice following treatment with anti-CTLA4 antibody.
Heinzel FP; Maier RA
Infect Immun; 1999 Dec; 67(12):6454-60. PubMed ID: 10569763
[TBL] [Abstract][Full Text] [Related]
17. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
[TBL] [Abstract][Full Text] [Related]
18. Primed antigen-specific CD4+ T cells are required for NK cell activation in vivo upon Leishmania major infection.
Bihl F; Pecheur J; Bréart B; Poupon G; Cazareth J; Julia V; Glaichenhaus N; Braud VM
J Immunol; 2010 Aug; 185(4):2174-81. PubMed ID: 20624944
[TBL] [Abstract][Full Text] [Related]
19. T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine.
Schwarz T; Remer KA; Nahrendorf W; Masic A; Siewe L; Müller W; Roers A; Moll H
PLoS Pathog; 2013; 9(6):e1003476. PubMed ID: 23825956
[TBL] [Abstract][Full Text] [Related]
20. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages.
Kennedy MK; Picha KS; Fanslow WC; Grabstein KH; Alderson MR; Clifford KN; Chin WA; Mohler KM
Eur J Immunol; 1996 Feb; 26(2):370-8. PubMed ID: 8617306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
